# EDGAR Filing Document

**Accession Number:** 0001467373
**File Stem:** 0001467373-26-000007
**Filing Date:** 2026-2
**Character Count:** 37522
**Document Hash:** c624672faa8bc1d6d805da752376397f
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001467373-26-000007.hdr.sgml**: 20260204

**ACCESSION NUMBER**: 0001467373-26-000007

**CONFORMED SUBMISSION TYPE**: S-8

**PUBLIC DOCUMENT COUNT**: 14

**REFERENCES 429**: 333-164737

**REFERENCES 429**: 333-188134

**REFERENCES 429**: 333-210973

**REFERENCES 429**: 333-222927

**REFERENCES 429**: 333-236196

**REFERENCES 429**: 333-262371

**REFERENCES 429**: 333-276820

**REFERENCES 429**: 333-65376-99

**FILED AS OF DATE**: 20260204

**DATE AS OF CHANGE**: 20260204

**EFFECTIVENESS DATE**: 20260204

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Accenture plc
- **CENTRAL INDEX KEY:** 0001467373
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-BUSINESS SERVICES, NEC [7389]
- **ORGANIZATION NAME:** 07 Trade & Services
- **EIN:** 980627530
- **STATE OF INCORPORATION:** L2
- **FISCAL YEAR END:** 0831

**FILING VALUES:**
- **FORM TYPE:** S-8
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-293195
- **FILM NUMBER:** 26598397

**BUSINESS ADDRESS:**
- **STREET 1:** 1 GRAND CANAL SQUARE
- **STREET 2:** GRAND CANAL HARBOUR
- **CITY:** DUBLIN
- **STATE:** L2
- **ZIP:** D2
- **BUSINESS PHONE:** 353-1-646-2000

**MAIL ADDRESS:**
- **STREET 1:** 1 GRAND CANAL SQUARE
- **STREET 2:** GRAND CANAL HARBOUR
- **CITY:** DUBLIN
- **STATE:** L2
- **ZIP:** D2

**As filed with the Securities and Exchange Commission on February 4, 2026**

**Registration No. 333-**

**UNITED STATES SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

<u>______________________________________</u>

**FORM S-8**

**REGISTRATION STATEMENT**

**UNDER**

**THE SECURITIES ACT OF 1933**

<u>______________________________________</u>

**Accenture plc**

(Exact name of registrant as specified in its charter)

<u>______________________________________</u>

---

| | |
|:---|:---|
| **Ireland** | **98-0627530** |
| *(State or other jurisdiction of*<br>*incorporation or organization)* | *(I.R.S. Employer*<br>*Identification No.)* |

---

<u>______________________________________</u>

**1 Grand Canal Square**

**Grand Canal Harbour**

**Dublin 2, Ireland**

**(353) (1) 646-2000**

(Address, including zip code, of registrant's principal executive offices)

<u>______________________________________</u>

**Amended and Restated Accenture plc 2010 Share Incentive Plan**

(Full title of the plan)

<u>______________________________________</u>

**Joel Unruch, Esq.**

**Lilias Lee, Esq.**

**Accenture plc**

**500 W. Madison**

**Chicago, IL 60661**

**(312) 693-0161**

(Name, address, including zip code, and telephone number, including area code, of agent for service)

<u>______________________________________</u>

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act.

------

**As filed with the Securities and Exchange Commission on February 4, 2026**

**Registration No. 333-**

---

| | |
|:---|:---|
| Large accelerated filer  | Accelerated filer ☐ |
| Non-accelerated filer ☐ (Do not check if a smaller reporting company) | Smaller Reporting Company ☐ |
| | Emerging Growth Company ☐ |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

------

**EXPLANATORY NOTE**

On January 28, 2026, at the 2026 annual general meeting of shareholders of Accenture plc (the "Company" or the "Registrant"), the Company's shareholders approved an amendment and restatement of the Amended and Restated Accenture plc 2010 Share Incentive Plan (the "SIP", and as so amended and restated, the "Amended SIP"). The SIP provides for grants of equity awards to designated employees, directors, consultants and other service providers of the Company and its affiliates. The Amended SIP provides that the number of the Company's Class A ordinary shares, par value $0.0000225 (the "Shares"), which may be granted under the Amended SIP would be increased by 7,000,000 Shares in addition to the 141,000,000 Shares which were previously authorized for issuance under the SIP.

This Registration Statement on Form S-8 (this "Registration Statement") relates to (i) the additional 7,000,000 Shares authorized to be issued under the Amended SIP and (ii) 1,000,000 Shares that may become available for issuance under the Amended SIP as a result of outstanding awards that, in whole or in part, are terminated, expire or are otherwise cancelled.

**PART I** 

**INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS** 

The information required in Part I of this Registration Statement is included in one or more prospectuses for the Amended SIP that are not filed as part of this Registration Statement in accordance with Rule 428 under the Securities Act of 1933, as amended (the "Securities Act") and the Note to Part I of Form S-8.

**PART II**

**INFORMATION REQUIRED IN THE REGISTRATION STATEMENT** 

**Item 3. &nbsp;&nbsp;&nbsp;&nbsp;Incorporation of Documents by Reference.**

The following documents filed by the Company with the Securities and Exchange Commission (the "Commission") pursuant to the Securities Exchange Act of 1934, as amended (the "Exchange Act"), are hereby incorporated by reference (excluding any information "furnished," but not "filed" with the Commission) in this Registration Statement:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)The Company's Annual Report on Form 10-K for the fiscal year ended August 31, 2025.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)The Company's Quarterly Report on Form 10-Q for the quarterly period ended November 30, 2025.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)The Company's Current Report on Form 8-K filed on January 28, 2026.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)The Company's Current Report on Form 8-K12B, filed September 1, 2009 with the Commission under Section 12(b) of the Exchange Act, including the description of the Company's Class A ordinary shares contained therein, and the Current Reports of the Company on Form 8-K (under Items 5.03 and 9.01), filed on February 9, 2012, February 3, 2016 and February 7, 2018 and in Exhibit 4.1 to the Company's Annual Report on Form 10-K filed on October 10, 2024.

All documents filed by the Company pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act (other than information furnished pursuant to Item 2.02 or 7.01 of any Current Report on Form 8-K, unless expressly stated otherwise therein) after the date of this Registration Statement and prior to the filing of a post-effective amendment to this Registration Statement which indicates that all securities offered have been sold or which deregisters all securities then remaining unsold shall be deemed to be incorporated by reference in this

------

Registration Statement and to be a part hereof from the date of filing such documents. Any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained herein or in any other subsequently filed document which also is or is deemed to be incorporated by reference herein modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.

**Item 4.&nbsp;&nbsp;&nbsp;&nbsp;Description of Securities.**

Not applicable.

**Item 5.&nbsp;&nbsp;&nbsp;&nbsp;Interests of Named Experts and Counsel.** 

None.

**Item 6.&nbsp;&nbsp;&nbsp;&nbsp;Indemnification of Directors and Officers.** 

If an officer (within the meaning of Irish law, which includes the directors, the secretary and assistant secretaries) of an Irish company is found to have breached his or her fiduciary duties to that company, he or she may be held personally liable to the company in respect of that breach of duty. The Company's articles of association contain indemnification and expense advancement provisions for persons who are not officers (within the meaning of Irish law) of the Company. The Company's articles of association also confer a more limited indemnity on its officers (within the meaning of Irish law) for certain costs and discharge the liability of such officers where judgment is given in favor of any such officer in any civil or criminal action in respect of such costs or liability, or where an Irish court grants relief because any such officer acted honestly and reasonably and ought fairly to be excused. This restriction does not apply to executives or officers who are not officers (within the meaning of Irish law) of the Company. Any provision which seeks to indemnify an officer (within the meaning of Irish law) of an Irish company over and above this shall be void under Irish law, whether contained in its articles of association or any contract between such officer and the company.

Under Irish law, the Company may not exempt its officers (within the meaning of Irish law) from liability for negligence or a breach of duty. However, where a breach of duty has been established, such officers may be statutorily exempted by an Irish court from personal liability for negligence or breach of duty if, among other things, the court determines that they have acted honestly and reasonably, and that they may fairly be excused as a result.

In accordance with Irish law, the Company has taken out directors and officers liability insurance, as well as other types of insurance, for our directors and officers.

In addition, Accenture Inc. has entered into indemnification agreements with each of the Company's directors providing for the indemnification of, and advancement of expenses to, these persons.

**Item 7. &nbsp;&nbsp;&nbsp;&nbsp;Exemption from Registration Claimed.**

None.

**Item 8.&nbsp;&nbsp;&nbsp;&nbsp;Exhibits.** 

See exhibits listed under the Exhibit Index below.

**Item 9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Undertakings.** 

(a) The undersigned Registrant hereby undertakes:

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) To file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) To include any prospectus required by Section 10(a)(3) of the Securities Act;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) To reflect in the prospectus any facts or events arising after the effective date of this Registration Statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in this Registration Statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than 20% change in the maximum aggregate offering price set forth in the "Calculation of Filing Fee Table" in the effective registration statement; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) To include any material information with respect to the plan of distribution not previously disclosed in this Registration Statement or any material change to such information in this Registration Statement;

*provided*, *however*, that the undertakings set forth in paragraphs (a)(1)(i) and (a)(1)(ii) above do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the Registrant pursuant to Section 13 or Section 15(d) of the Exchange Act that are incorporated by reference in this Registration Statement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3) To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.

(b) The undersigned Registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the Registrant's annual report pursuant to Section 13(a) or Section 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan's annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in this Registration Statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

(c) Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.

------

**SIGNATURES** 

Pursuant to the requirements of the Securities Act, the Company certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Dublin, Ireland, on February 4, 2026.

---

| | |
|:---|:---|
| **ACCENTURE PLC** | **ACCENTURE PLC** |
| By: | /s/ JOEL UNRUCH |
| Name: | Joel Unruch |
| Title: | General Counsel & Corporate Secretary |

---

**POWER OF ATTORNEY** 

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below hereby constitutes and appoints Julie Sweet, Angie Park, Joel Unruch and Lilias Lee, and each of them, as his or her true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for him or her in his or her name, place and stead, in any and all capacities, in connection with this Registration Statement, including to sign and file in the name and on behalf of the undersigned as director or officer of the Registrant (1) any and all amendments or supplements (including any and all stickers and post-effective amendments) to this Registration Statement, with all exhibits thereto, and other documents in connection therewith, and (2) any and all additional registration statements, and any and all amendments thereto, relating to the same offering of securities as those that are covered by this Registration Statement that are filed pursuant to Rule 462(b) promulgated under the Securities Act with the Commission and any applicable securities exchange or securities self-regulatory body, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite or necessary to be done in and about the premises, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them, or their substitutes, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirement of the Securities Act, this Registration Statement has been signed by the following persons in the capacities and on the date indicated.

------

---

| | | |
|:---|:---|:---|
| Signature | Title | Date |
| /s/ JULIE SWEET | Chief Executive Officer, Chair of the Board and Director | February 4, 2026 |
| Julie Sweet | (principal executive officer) |  |
| /s/ ANGIE PARK | Chief Financial Officer | February 4, 2026 |
| Angie Park | (principal financial officer) |  |
| /s/ MELISSA A. BURGUM | Chief Accounting Officer | February 4, 2026 |
| Melissa A. Burgum | (principal accounting officer) |  |
| /s/ ARUN SARIN | Lead Director | February 4, 2026 |
| Arun Sarin |  |  |
| /s/ MARTIN BRUDERMÜLLER | Director | February 4, 2026 |
| Martin Brudermüller |  |  |
| /s/ ALAN JOPE | Director | February 4, 2026 |
| Alan Jope |  |  |
| /s/ NANCY McKINSTRY | Director | February 4, 2026 |
| Nancy McKinstry |  |  |
| /s/ JENNIFER NASON | Director | February 4, 2026 |
| Jennifer Nason |  |  |
| /s/ PAULA A. PRICE | Director | February 4, 2026 |
| Paula A. Price |  |  |
| /s/ VENKATA S.M. RENDUCHINTALA | Director | February 4, 2026 |
| Venkata S.M. Renduchintala |  |  |
| /s/ TRACEY T. TRAVIS | Director | February 4, 2026 |
| Tracey T. Travis |  |  |
| /s/ MASAHIKO UOTANI | Director | February 4, 2026 |
| Masahiko Uotani |  |  |
| /s/ JOEL UNRUCH | Authorized Representative in the | February 4, 2026 |
| Joel Unruch | United States |  |

---

------

**EXHIBIT INDEX**

---

| | |
|:---|:---|
| **Exhibit No.** | **Exhibit Description** |
| 4.1 | Certificate of Incorporation of Accenture plc (incorporated by reference to <u>[Exhibit 3.2 to Accenture plc's 8-K12B filed on September 1, 2009](https://www.sec.gov/Archives/edgar/data/1467373/000119312509185098/dex32.htm)</u>) |
| 4.2 | Amended and Restated Memorandum and Articles of Association of Accenture plc (incorporated by reference to <u>[Exhibit 3.1 to Accenture plc's 8-K filed on February 7, 2018](https://www.sec.gov/Archives/edgar/data/1467373/000146737318000078/exhibit31amendedandrestate.htm)</u>) |
| 5.1 | Opinion of Arthur Cox LLP, Solicitors, as to the legality of the Class A ordinary shares being registered (<u>[filed herewith](acn02042026s-8ex51opiniono.htm)</u>) |
| 23.1 | Consent of KPMG LLP (<u>[filed herewith](acn02042026s-8ex231xkpmgco.htm)</u>) |
| 23.2 | Consent of Arthur Cox LLP, Solicitors (<u>[included as part of Exhibit 5.1](acn02042026s-8ex51opiniono.htm)</u>) |
| 24.1 | Power of Attorney (<u>[included on the signature page hereto](#ibe83fd1727a84e54a6286e57641ea093_7)</u>) |
| 99.1 | Amended and Restated Accenture plc 2010 Share Incentive Plan (incorporated by reference to <u>[Exhibit 10.1 to Accenture plc's 8-K filed on January](https://www.sec.gov/Archives/edgar/data/1467373/000146737326000005/acn01282026agmex101ar2010s.htm)[28](https://www.sec.gov/Archives/edgar/data/1467373/000146737326000005/acn01282026agmex101ar2010s.htm)[, 202](https://www.sec.gov/Archives/edgar/data/1467373/000146737326000005/acn01282026agmex101ar2010s.htm)[6](https://www.sec.gov/Archives/edgar/data/1467373/000146737326000005/acn01282026agmex101ar2010s.htm)</u>) |
| 107.1 | Filing Fee Table (<u>[filed herewith](exfilingfees.htm)</u>) |

---

## Ex-Filing

?xml version='1.0' encoding='ASCII'? exfilingfees

**Exhibit 107.1**

**Calculation of Filing Fee Table**

**FORM S-8**

(Form Type)

**Accenture plc**

(Exact Name of Registrant as Specified in its Charter)

<u>Table 1: Newly Registered Securities</u> 

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Security Type** | **Security Class Title (1)** | **Fee Calculation Rule** | **Amount Registered** | **Proposed Maximum<br>Offering Price Per Unit** | **Maximum<br>Aggregate<br>Offering Price** | **Fee Rate** | **Amount of<br>Registration Fee** |
| Equity (2) | Class A ordinary shares, par value $0.0000225 per share | Rule 457(a)  | 8000000 | $262.22 | $2097760000 | $138.10 per $1,000,000 | $289700.66 |
| **Total Offering Amounts** | **Total Offering Amounts** | **Total Offering Amounts** | **Total Offering Amounts** |  | $2097760000 |  | $289700.66 |
| **Total Fee Offsets** | **Total Fee Offsets** | **Total Fee Offsets** | **Total Fee Offsets** |  |  |  |  |
| **Net Fee Due** | **Net Fee Due** | **Net Fee Due** | **Net Fee Due** |  |  |  | $289700.66 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the "Securities Act"), this Registration Statement shall also cover an indeterminable number of additional Class A ordinary shares, par value $0.0000225 per share (the "Shares") that may become issuable under the Amended and Restated Accenture plc 2010 Share Incentive Plan (the "Amended SIP") to prevent dilution in the event of stock splits, stock dividends and other anti-dilution provisions.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)&nbsp;&nbsp;&nbsp;&nbsp;The "Proposed Maximum Offering Price Per Unit" and "Maximum Aggregate Offering Price" are estimated solely for the purpose of calculating the registration fee pursuant to Rules 457(c) and (h) under the Securities Act based on the average of the high and low sales prices of the Shares, as quoted on the New York Stock Exchange on January 30, 2026. The "Amount Registered" represents (i) 7,000,000 Shares being registered for issuance pursuant to the Amended SIP and (ii) 1,000,000 Shares that may become available for issuance under the Amended SIP as a result of outstanding awards that are terminated, expire or are otherwise cancelled.

## Exhibit 5.1

**Exhibit 5.1**

4 February 2026

To:&nbsp;&nbsp;&nbsp;&nbsp;Board of Directors

Accenture plc

1 Grand Canal Square

Grand Canal Harbour

Dublin 2

Re:&nbsp;&nbsp;&nbsp;&nbsp;**Accenture plc Registration Statement on Form S-8 in relation to the Plan**

Ladies and Gentlemen,

**1. Basis of Opinion**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.1&nbsp;&nbsp;&nbsp;&nbsp;We are acting as Irish counsel to Accenture plc, a public company limited by shares, incorporated under the laws of Ireland, with its registered office at 1 Grand Canal Square, Grand Canal Harbour, Dublin 2 (the "**Company**"), in connection with the filing by the Company of a registration statement on Form S-8 (the "**Registration Statement**") with the United States Securities and Exchange Commission (the "**SEC**") on or around the date hereof under the Securities Act of 1933, as amended (the "**Securities Act**"), relating to the registration of Class A ordinary shares with nominal value US$0.0000225 of the Company (the "**Shares**") that may be delivered pursuant to the Company's Amended and Restated 2010 Share Incentive Plan (the "**Plan**").

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.2&nbsp;&nbsp;&nbsp;&nbsp;This Opinion is confined to, given in all respects on the basis of, governed by and is to be construed in accordance with, the laws of Ireland (meaning Ireland exclusive of Northern Ireland) in force as at the date hereof as currently applied and interpreted by the courts of Ireland. We have made no investigation of and we express no opinion as to the laws of any other jurisdiction or the effect thereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.3&nbsp;&nbsp;&nbsp;&nbsp;This Opinion is also strictly confined to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;the matters expressly stated herein at paragraph 2 below and is not to be read as extending by implication or otherwise to any other matter;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;the Documents (as defined in Schedule 1); and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;&nbsp;&nbsp;the searches listed at paragraph 1.5 below.

------

We express no opinion, and make no representation or warranty, as to any matter of fact or in respect of any documents which may exist in relation to the Plan other than the Documents.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.4&nbsp;&nbsp;&nbsp;&nbsp;For the purpose of giving this Opinion, we have examined copies sent to us by email in pdf or other electronic format of the Documents.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.5&nbsp;&nbsp;&nbsp;&nbsp;For the purpose of giving this Opinion, we have caused to be made the following legal searches against the Company on or about the date hereof:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;on the file of the Company maintained by the Companies Registration Office, Dublin (the "CRO") for returns of allotments, special resolutions amending the Memorandum and Articles of Association of the Company and notice of the appointment of directors and secretary of the Company and for the appointment of any receiver, examiner or liquidator;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;in the Judgments Office of the High Court of Ireland; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;&nbsp;&nbsp;in the Central Office of the High Court of Dublin for any proceedings or petitions filed.

**2.**&nbsp;&nbsp;&nbsp;&nbsp;**Opinion**

Subject to the assumptions and qualifications set out in this Opinion and to any matters not disclosed to us, we are of the opinion that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.1&nbsp;&nbsp;&nbsp;&nbsp;the Company is a public company limited by shares, is duly incorporated and validly existing under the laws of Ireland and has the requisite corporate authority to issue the Shares; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.2&nbsp;&nbsp;&nbsp;&nbsp;when the Shares have been issued and, if required, paid for pursuant to and in accordance with the terms and conditions referred to or summarized in the applicable resolutions and the Plan, the Shares will be validly issued, fully paid up and non-assessable (which term means when used herein that no further sums are required to be paid by the holders thereof in connection with the issue of such shares).

**3.**&nbsp;&nbsp;&nbsp;&nbsp;**Assumptions**

For the purpose of giving this Opinion, we assume the following without any responsibility on our part if any assumption proves to have been untrue as we have not verified independently any assumption:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.1&nbsp;&nbsp;&nbsp;&nbsp;that the Company will receive consideration equal to the aggregate of the nominal value and any premium required to be paid up on the Shares issued pursuant to awards under the Plan and that such consideration will be in cash and/or otherwise provided in accordance with Irish law;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.2&nbsp;&nbsp;&nbsp;&nbsp;that the filing of the Registration Statement with the SEC has been authorized by all necessary actions under all applicable laws other than Irish law;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.3&nbsp;&nbsp;&nbsp;&nbsp;that the vesting of any awards granted under the Plan and the issue of the Shares upon vesting of such awards (and the issue of the Shares in connection with any

------

other awards granted under the Plan) will be conducted in accordance with the terms and the procedures described in the Plan and the applicable award agreement;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.4&nbsp;&nbsp;&nbsp;&nbsp;that the exercise of any options granted under the Plan and the issue of the Shares upon exercise of such options (and the issue of the Shares in connection with any other awards granted under the Plan) will be conducted in accordance with the terms and the procedures described in the Plan and the applicable award or enrolment agreement, as the case may be;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.5&nbsp;&nbsp;&nbsp;&nbsp;with respect to Shares issued on or after 28 July 2027 (the date of expiry of the Company's existing authority to issue Shares), that the Company will have renewed its authority to issue the Shares in accordance with the terms and conditions set out in the Articles of Association of the Company and the Companies Act 2014 of Ireland for the remainder of the period that the Registration Statement will continue in effect;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.6&nbsp;&nbsp;&nbsp;&nbsp;with respect to Shares issued on or after 28 July 2027 (the date of expiry of the Company's existing determination of the re-allotment price of any shares which constitute treasury shares), that the Company has determined at a general meeting in accordance with Sections 109 and/or 1078 of the Companies Act 2014 of Ireland the re-allotment price of any Shares which constitute treasury shares;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.7&nbsp;&nbsp;&nbsp;&nbsp;that, at the time of grant or issue by the Compensation, Culture & People Committee of the board of directors of the Company (the "**Committee**") of any award or Share under the Plan, the Committee has been duly constituted and remains a duly constituted committee of the board of directors of the Company having the necessary powers and authorities to issue awards and the Shares;

*Authenticity and bona fides*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.8&nbsp;&nbsp;&nbsp;&nbsp;the completeness and authenticity of all documents submitted to us as originals or copies of originals and (in the case of copies) conformity to the originals of copy documents and the genuineness of all signatories (electronic or otherwise), stamps and seals thereon;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.9&nbsp;&nbsp;&nbsp;&nbsp;where incomplete Documents have been submitted to us or signature pages only have been supplied to us for the purposes of issuing this Opinion, that the originals of such Documents correspond in all respects with the last draft of the complete Documents submitted to us;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.10&nbsp;&nbsp;&nbsp;&nbsp;that the terms of the Documents will be observed and performed by the parties thereto;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.11&nbsp;&nbsp;&nbsp;&nbsp;that the copies produced to us of minutes of meetings and/or of resolutions correctly record the proceedings at such meetings and/or the subject matter which they purport to record and that any meetings referred to in such copies were duly convened, duly quorate and held, that those present at any such meetings were entitled to attend and vote at the meeting, and acted bona fide throughout and that no further resolutions have been passed or other action taken which would or might alter the effectiveness thereof;

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.12&nbsp;&nbsp;&nbsp;&nbsp;that the Memorandum and Articles of Association of the Company amended on 7 February 2018 are the current Memorandum and Articles of Association of the Company, are up to date and have not been amended or superseded and that there are no other terms governing the Shares other than those set out in the Memorandum and Articles of Association of the Company;

*Accuracy of searches and warranties*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.13&nbsp;&nbsp;&nbsp;&nbsp;the accuracy and completeness of the information disclosed in the searches referred to in paragraph 1.5 above and that such information has not since the time of such search or enquiry been altered. It should be noted that;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;the position reflected by the searches may not be fully up to date; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;searches at the CRO do not necessarily reveal whether or not a prior charge has been created or a resolution has been passed or a petition presented or any other action taken for the winding-up of or the appointment of a receiver or an examiner to the Company;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.14&nbsp;&nbsp;&nbsp;&nbsp;the truth, completeness and accuracy of all representations and statements as to factual matters contained in the Documents; and

*Commercial Benefit*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.15&nbsp;&nbsp;&nbsp;&nbsp;that the Documents have been entered into for bona fide commercial purposes, on arm's length terms and for the benefit of each party thereto and are in those parties' respective commercial interest and for their respective corporate benefit.

**4.**&nbsp;&nbsp;&nbsp;&nbsp;**Disclosure**

This Opinion is addressed to you in connection with the registration of the Shares with the SEC. We hereby consent to the inclusion of this Opinion as an exhibit to the Registration Statement to be filed with the SEC. In giving this consent, we do not thereby admit that we are in a category of person whose consent is required under Section 7 of the Securities Act.

Yours faithfully,

<u>/s/ Arthur Cox LLP</u>

ARTHUR COX LLP

------

**SCHEDULE 1**

**DOCUMENTS**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.A copy of the form of the Registration Statement to be filed by the Company with the SEC;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.A copy of the Plan;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.A copy of the resolutions of the board of directors of the Company delegating authority to the Committee to approve amendments to the Plan dated 20 October 2025;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.A copy of the resolutions of the Committee approving amendments to the Plan dated 8 December 2025;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.A copy of the resolutions of the board of directors of the Company ratifying the Committee's approval of the Plan and approving the Plan dated 28 January 2026;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.A copy of the resolutions of the board of directors of the Company approving the filing of the Registration Statement dated 28 January 2026;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.A copy of the Memorandum and Articles of Association of the Company as amended by resolutions of the shareholders of the Company on 7 February 2018;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8.A copy of the certificate from an authorised officer of the Company dated 3 February 2026 in relation to the 2026 annual general meeting and the share capital of the Company; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9.A printout from the CRO dated 4 February 2026 confirming status of the Company as normal.

## Exhibit 23.1

**Exhibit 23.1**

**Consent of Independent Registered Public Accounting Firm**

We consent to the use of our report dated October 10, 2025, with respect to the consolidated financial statements of Accenture plc, and the effectiveness of internal control over financial reporting, incorporated herein by reference.

**/s/ KPMG LLP**

Chicago, Illinois<br>February 4, 2026

<br>